230 related articles for article (PubMed ID: 20453882)
21. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
22. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.
Klauzinska M; Baljinnyam B; Raafat A; Rodriguez-Canales J; Strizzi L; Greer YE; Rubin JS; Callahan R
J Cell Physiol; 2012 May; 227(5):1960-71. PubMed ID: 21732367
[TBL] [Abstract][Full Text] [Related]
23. The RARgamma selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis.
Jiang SY; Lin DY; Shyu RY; Reichert U; Yeh MY
Cancer Lett; 1999 Apr; 137(2):217-25. PubMed ID: 10374844
[TBL] [Abstract][Full Text] [Related]
24. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
[TBL] [Abstract][Full Text] [Related]
25. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
Campbell MJ; Wollish WS; Lobo M; Esserman LJ
In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological characterization of Disila-AM80 (Disila-tamibarotene) and Disila-AM580, silicon analogues of the RARalpha-selective retinoid agonists AM80 (Tamibarotene) and AM580.
Tacke R; Müller V; Büttner MW; Lippert WP; Bertermann R; Daiss JO; Khanwalkar H; Furst A; Gaudon C; Gronemeyer H
ChemMedChem; 2009 Nov; 4(11):1797-802. PubMed ID: 19790202
[No Abstract] [Full Text] [Related]
27. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.
Liu X; Giguère V
Nucl Recept Signal; 2014; 12():e004. PubMed ID: 25422594
[TBL] [Abstract][Full Text] [Related]
29. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
30. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
[TBL] [Abstract][Full Text] [Related]
31. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
32. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cells and cells of origin in MMTV-Her2/neu-induced mammary tumorigenesis.
Lo PK; Chen H
Oncogene; 2013 Mar; 32(10):1338-40. PubMed ID: 23045276
[No Abstract] [Full Text] [Related]
34. Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity.
Zhang ZP; Hutcheson JM; Poynton HC; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2003 Jan; 409(2):375-84. PubMed ID: 12504905
[TBL] [Abstract][Full Text] [Related]
35. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
36. Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure.
Zhong Y; Wu Y; Liu R; Deng Y; Mallipattu SK; Klotman PE; Chuang PY; He JC
Kidney Int; 2012 May; 81(9):856-64. PubMed ID: 22258322
[TBL] [Abstract][Full Text] [Related]
37. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
Huang S; Chen Y; Podsypanina K; Li Y
Neoplasia; 2008 Feb; 10(2):118-24. PubMed ID: 18283333
[TBL] [Abstract][Full Text] [Related]
38. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
39. Bexarotene induces cellular senescence in MMTV-Neu mouse model of mammary carcinogenesis.
Shilkaitis A; Bratescu L; Green A; Yamada T; Christov K
Cancer Prev Res (Phila); 2013 Apr; 6(4):299-308. PubMed ID: 23430755
[TBL] [Abstract][Full Text] [Related]
40. Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; Lamph WW; Vannini N; Sogno I; Albini A; Sporn MB
Clin Cancer Res; 2008 Jul; 14(14):4556-63. PubMed ID: 18628471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
